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airway epithelium consists of squamous metaplasia/dysplasia/carci-
noma in situ associated with invasive squamous cell carcinoma, which 
is very rare in mouse lung. Interestingly, the treatment with N-nitroso-
tris-chloroethylurea by skin painting of inbred mice induced pulmonary 
squamous cell carcinoma with premalignant changes in a strain-depen-
dent manner (9). Preliminary reports of GEM models include induction 
of the squamous differentiation program by overexpression of human 
keratin 14 in the airway epithelium (10), and involvement of Lkb1 with 
mouse squamous cell lung cancer (11). 
New directions for mouse models 
A newer generation of compound conditional mouse models are aimed 
to integrate varied features of existing models and develop new ones 
(1). For example, lung tumors in compound mice with conditional 
mutations in the K-ras proto-oncogene and different alleles of p53 
tumor suppressor gene are associated with stromal metaplasia and 
distant metastases characteristic of human lung adenocarcinomas. It has 
become obvious that human lung cancer has complex genetics which 
will require complex mouse models.
Recent studies of cross-species comparisons of cancer signaling have 
detected marked similarities in mouse and human lung tumorigenesis 
using gene proﬁling (12,13). This approach has also been extended 
to establish signatures for aggressive tumors of lung and other organs 
using SV40 transgenic mice (14). The reports provide a new molecular 
criterion for validating lung tumor models and potential clues for yet 
unappreciated pathways in human tumors.
Advances in imaging technologies parallel development of GEM. 
Discoveries through gene expression proﬁling in GEMs have led novel 
in vivo imaging techniques of mouse lung tumors using an optical 
probe activated cathepsin proteases (15). Yet another approach has been 
the generation of a conditional luciferase reporter mouse that enables 
bioluminescence imaging of tumorigenesis (16). 
The most frequently used model for chemoprevention studies has 
been the A/J mouse. Recent studies have incorporated the mutant A/J 
mouse with genetic alterations in p53, K-ras or Ink4A/Arf, which are 
commonly involved in human lung tumorigenesis and facilitate the 
adenoma-carcinoma assessment (17,18). Moreover genetic signatures 
for such chemopreventive agents as green tea and budenoside and 
treatment with Geﬁtinib have been established using cDNA microarray 
analysis on mouse lung tumors (19, 20). 
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Background. 
The expression of the catalytic subunit of human telomerase (hTERT) 
produces telomerase activity and circumvents telomere-based repli-
cative aging in normal cells. We have used hTERT to immortalize a 
variety of human cell types including skin keratinocytes and ﬁbroblasts, 
muscle satellite cells, breast epithelial and stromal ﬁbroblast cells, and 
both corneal epithelial cells and ﬁbroblasts (keratocytes). Corneal epi-
thelial cells expressing introduced hTERT require growth on collagen 
IV while both breast epithelial cells and skin keratinocytes require 
feeder layers to prevent a premature p16-induced growth arrest due to 
inadequate culture conditions. Human corneal and skin cells expressing 
hTERT can be used to form organotypic (3D) cultures. Stromal cells 
are mixed with collagen type I, permitted to contract, and then placed 
on a porous membrane in a transwell dish. The hTERT immortalized 
epithelial cells are then layered on top of the stromal cell/collagen 
plug the cells are exposed to air instead of being submerged in culture 
medium. Such organotypic cultures express differentiation-speciﬁc 
proteins, demonstrating that hTERT does not grossly alter the differen-
tiation phenotype. 
Immortalization of Human Bronchial Epithelial Cells (HBECs) 
with CDK4 and hTERT. 
The optimal culture conditions to immortalize human bronchial 
epithelial cells (HBEC) with only ectopically introduced hTERT have 
not been determined, and thus we expressed both hTERT and cdk4 (to 
bypass upregulated p16). In organotypic (3D) culture, cdk4 + hTERT 
immortalized human bronchial epithelial cells are placed on top of 
collagen plugs contracted by normal human lung ﬁbroblasts and then 
exposed to an air-medium interface and allowed to differentiate. One 
immortal clone HBEC3-KT is able to differentiate into both mucous 
(goblet) and ciliated epithelial cells when placed in 3D cultures. Thus 
these cells may have wide utility in investigating normal morphogen-
esis and diseases associated with lung dysfunction. In addition, these 
cells also provide a novel cellular resource to study the molecular 
pathogenesis of lung cancer. 
Characterization of HBECS. 
In addition to studying their ability to differentiate in 3D organotypic 
culture, we have performed expression proﬁling (Affymetrix and Il-
lumina arrays) and Q RT-PCR expression proﬁling of the immortalized 
compared to non immortal HBECs. We have deﬁned gene expression 
signatures, of a panel of 30 stem cell genes that show dramatic expres-
sion changes with immortalization (such as changes in Notch1, Hey2, 
Jag1, DLL1, Sox2, and Smo).
Isogenic Oncogenic Manipulation of HBECs. 
In the HBEC3-KT immortalized cells we have stably knocked down 
p53 using a shRNA and also over-expressed the transforming onco-
gene, K-rasV12. The HBEC3-KT cells with knockdown of p53 and 
over-expression of K-rasV12 invade into the ﬁbroblast stromal matrix 
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
Copyright © 2007 by the International Association for the Study of Lung CancerS182
in 3D cultures instead of differentiating into mucous and ciliated differ-
entiated cells. These cells can also grow as large colonies when placed 
in soft agar and when such colonies are introduced into the lungs of 
immunosuppressed mice, some colonies develop into squamous cell 
carcinoma and in other animals they develop into adenocarcinoma. 
This suggests that these immortalized and transformed HBECs have 
bronchiolar-alveolar stem-like characteristics that can differentiate into 
squamous cell and adenocarcinoma non small cell lung cancer. 
Stem cells are deﬁned by both their ability to make more stem cells 
(self renewal) and their ability to produce cells that can differentiate. 
Human bronchial epithelial cells expressing cdk4 and hTERT fulﬁll this 
deﬁnition of normal stem cells by continuous self renewal and by hav-
ing the capability of differentiating into both mucous and ciliated epi-
thelial cells. Thus, 3D organotypic cultures bridge standard monolayer 
culture (2D) with those of animal models of lung cancer and should be 
important for developing a fuller understanding of the pathogenesis of 
human lung cancer. In summary, the production of hTERT engineered 
cells offer the possibility of producing tissues to model a variety of 
diseases and aged-related medical conditions.
Targeting Telomerase in Lung Cancer Stem Cells. 
Similar to normal stem cells, cancer stem cells also have the ability to 
self-renew as well as undergo differentiation to give rise to the phe-
notypically diverse types of cancer cells. The implications of this is if 
only a rare subset of tumor stem cells drives tumor formation, then the 
goal of cancer therapy should be to identify this population of cells and 
to develop therapies that target unique mechanisms that are only active 
in cancer stem cells, sparing normal tissue stem cells. As part of our 
anti-telomerase therapeutics program, we have addressed the follow-
ing question: Will telomerase inhibitors not only target the bulk of the 
tumor cell population but also the rarer cancer stem cells? 
Normal stem cells have longer telomeres compared to cancer stem 
cells, thus we believe there may be a window of opportunity to target 
cancer stems cells by inhibiting telomerase and driving telomeres short 
and cells into apoptotic cell death, hopefully without irreversible dam-
age to normal stem cells. While the characteristics of the cancer stem of 
human lung cancer are not presently known, we have examined almost 
all cancer stem cell putative markers. In each case we have observed 
that puriﬁed lung cancer cells with putative markers for cancer stem 
cells are positive for telomerase activity and that an inhibitor currently 
being tested in early stage clinical trials, GRN163L, robustly inhibits 
the activity of telomerase in these sorted populations of cells as well as 
the mass population of cancer cells. 
Lung Cancer Stem Cell Like Properties Are Enriched in Lung 
Cancer Spheroids. 
We have begun to culture lung cancer cells as spheroids on non-ad-
herent culture dishes and have observed that many stem cell markers 
(e.g. Oct 4, Nanog, SOX2) are highly up-regulated when cultured as 
spheroids as opposed to normal adherent cell cultures. When such hu-
man lung spheroids are treated with GRN163L, we observe a decrease 
expression of these stem cell markers. Thus we propose that while can-
cer stem cells are maintained at low numbers in most solid tumors, the 
treatment of lung tumors with GRN163L may shift the stem cell popu-
lation into a depletion mode eventually leading to loss of the putative 
stem cell population. In summary, telomerase is a universal oncology 
target with high tumor speciﬁcity and we propose that anti-telomerase 
therapies (such as GRN163L) may target the cancer stem cell popula-
tion as well as the bulk of the tumor. 
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To address the lung cancer epidemic, beside antitobacco primary 
prevention efforts, early detection and chemoprevention strategies are 
needed. A better understanding of lung carcinogenesis is critical to 
improve chemoprevention strategies. The study of molecular abnor-
malities in preinvasive lesions represent one way to address the critical 
steps of lung tumor development. The identiﬁcation of molecular 
events involved in preinvasive lesions progression could lead to clinical 
studies with new molecular-targeted agents and the development of 
surrogate biomarkers. Such biomarkers are essential to select high-risk 
patients, select chemoprevention strategies and monitor drug efﬁcacy.
While morphological features of the airway mucosa of high risk indi-
viduals are well established, by themselves do not provide a satisfying 
predictive model of lung cancer development. The hypothesis pursued 
here is that molecular characteristics of the airway mucosa contains 
such information and that when applied with epidemiological, morpho-
logical and imaging related data elements, would provide a power-
ful tool to classify subjects at high risk for lung cancer and should 
ultimately personalize the management of lung cancer and reduce the 
overall mortality associated with this disease.
Access to these preinvasive lesions is provided by selection of high-
est risk group, autoﬂuoresence bronchoscopy or other endoscopic 
techniques that improve the sensitivity of detection of preinvasive 
dysplastic bronchial lesions. Morphological features and molecular ab-
normalities of such lesions have been described and can be monitored 
by follow-up bronchoscopies to validate potential chemoprevention 
treatments.
Bronchial specimen obtained from these high risk individuals lead to 
the report of a series of candidate biomarkers. These markers are being 
discovered through a series of methodologies advances that include 
polymerase chain reaction, genome-wide DNA copy number altera-
tions, expression arrays and proteomic strategies such as conventional 
